BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:TriGemX Bio readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of studies TriGemX Bio's drugs run\, from Cl
 inicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07645924-10397@assetmemo.bio
DTSTAMP:20261121T004103Z
DTSTART;VALUE=DATE:20270228
DTEND;VALUE=DATE:20270301
SUMMARY:Elismetrep: Phase 3 readout est. (NCT07645924)
DESCRIPTION:Elismetrep\, phase 3\, Migraine.\nStudy: A Study to Evaluate th
 e Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migr
 aine\nEstimated primary completion: February 2027. This is a ClinicalTrial
 s.gov estimate\, not a confirmed readout date\, and it can move.\nDrug pag
 e: https://assetmemo.bio/drug/elismetrep#upcoming-events\nRegistry record:
  https://clinicaltrials.gov/study/NCT07645924
URL:https://assetmemo.bio/drug/elismetrep#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07816367-10397@assetmemo.bio
DTSTAMP:20261121T004103Z
DTSTART;VALUE=DATE:20271031
DTEND;VALUE=DATE:20271101
SUMMARY:Elismetrep: Phase 3 readout est. (NCT07816367)
DESCRIPTION:Elismetrep\, phase 3\, Migraine.\nStudy: A Study to Assess the 
 Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migrai
 ne\nEstimated primary completion: October 2027. This is a ClinicalTrials.g
 ov estimate\, not a confirmed readout date\, and it can move.\nDrug page: 
 https://assetmemo.bio/drug/elismetrep#upcoming-events\nRegistry record: ht
 tps://clinicaltrials.gov/study/NCT07816367
URL:https://assetmemo.bio/drug/elismetrep#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07674654-10397@assetmemo.bio
DTSTAMP:20261121T004103Z
DTSTART;VALUE=DATE:20280630
DTEND;VALUE=DATE:20280701
SUMMARY:Elismetrep: Phase 3 readout est. (NCT07674654)
DESCRIPTION:Elismetrep\, phase 3\, Migraine.\nStudy: A Long-Term Safety Stu
 dy of Elismetrep (K-304) in the Acute Treatment of Migraine\nEstimated pri
 mary completion: June 2028. This is a ClinicalTrials.gov estimate\, not a 
 confirmed readout date\, and it can move.\nDrug page: https://assetmemo.bi
 o/drug/elismetrep#upcoming-events\nRegistry record: https://clinicaltrials
 .gov/study/NCT07674654
URL:https://assetmemo.bio/drug/elismetrep#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
